drugset / Trial / NCT00154076

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

NCT00154076

Phase 4 Completed 140 enrolled Eisai Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Timeline

Start
2005-09
Primary completion
2008-08
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Topiramate Small molecule 100 mg
Subject Zonisamide Other / unclassified 200 mg

Indications